Park Avenue Securities LLC Acquires 536 Shares of The Clorox Company (NYSE:CLX)

Park Avenue Securities LLC increased its holdings in shares of The Clorox Company (NYSE:CLXGet Rating) by 22.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,962 shares of the company’s stock after purchasing an additional 536 shares during the quarter. Park Avenue Securities LLC’s holdings in Clorox were worth $380,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. M&T Bank Corp grew its stake in shares of Clorox by 10.7% during the 2nd quarter. M&T Bank Corp now owns 31,464 shares of the company’s stock worth $4,060,000 after acquiring an additional 3,052 shares in the last quarter. SPC Financial Inc. bought a new position in shares of Clorox during the 3rd quarter worth approximately $200,000. Yousif Capital Management LLC grew its stake in shares of Clorox by 5.7% during the 2nd quarter. Yousif Capital Management LLC now owns 56,622 shares of the company’s stock worth $7,983,000 after acquiring an additional 3,055 shares in the last quarter. Exchange Traded Concepts LLC bought a new position in shares of Clorox during the 3rd quarter worth approximately $569,000. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its stake in shares of Clorox by 345.0% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 63,478 shares of the company’s stock worth $8,948,000 after acquiring an additional 49,213 shares in the last quarter. 79.12% of the stock is owned by institutional investors.

Clorox Trading Up 2.0 %

Shares of Clorox stock opened at $142.56 on Friday. The business has a fifty day simple moving average of $145.58 and a two-hundred day simple moving average of $143.16. The Clorox Company has a 1 year low of $120.50 and a 1 year high of $182.34. The company has a market capitalization of $17.59 billion, a price-to-earnings ratio of 43.73, a P/E/G ratio of 3.05 and a beta of 0.31. The company has a debt-to-equity ratio of 4.99, a current ratio of 0.88 and a quick ratio of 0.50.

Clorox (NYSE:CLXGet Rating) last posted its earnings results on Tuesday, November 1st. The company reported $0.93 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.20. Clorox had a return on equity of 83.00% and a net margin of 5.75%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.69 billion. Research analysts forecast that The Clorox Company will post 4.11 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Stockholders of record on Wednesday, January 25th will be issued a dividend of $1.18 per share. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.31%. The ex-dividend date of this dividend is Tuesday, January 24th. Clorox’s dividend payout ratio is currently 144.79%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CLX. Credit Suisse Group raised their price target on shares of Clorox from $130.00 to $135.00 and gave the stock an “underperform” rating in a research note on Wednesday, November 2nd. UBS Group raised their target price on shares of Clorox from $119.00 to $129.00 and gave the company a “sell” rating in a research note on Wednesday, November 2nd. Wells Fargo & Company raised their target price on shares of Clorox from $125.00 to $135.00 and gave the company an “underweight” rating in a research note on Tuesday, January 3rd. JPMorgan Chase & Co. raised their target price on shares of Clorox from $126.00 to $135.00 and gave the company an “underweight” rating in a research note on Friday, January 13th. Finally, Morgan Stanley raised their target price on shares of Clorox from $130.00 to $142.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 2nd. Nine research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and an average target price of $136.92.

Clorox Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXGet Rating).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.